Maximum quantity allowed is 999
Please select the quantity
CAS RN: 80621-81-4 | Product Number: R0101
Rifaximin
×
![]()
×
Purity: >97.0%(HPLC)(N)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
₩243,800
|
1 | 13 | Contact Us | |
| 5G |
₩778,100
|
6 | 1 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | R0101 |
Purity / Analysis Method 
|
>97.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__4__3H__5__1N__3O__1__1 = 785.89 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 80621-81-4 |
| Reaxys Registry Number | 3584528 |
| PubChem Substance ID | 172089119 |
| Merck Index (14) | 8220 |
| MDL Number | MFCD00864973 |
Specifications
| Appearance | Orange to Brown powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(with Total Nitrogen) | min. 96.0 % |
Properties (reference)
| Melting Point | 212 °C |
GHS
Related Laws:
| RTECS# | KD1576000 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Studies on the Antibacterial Activity of Rifaximin
References
- Rifaximin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria
- J. C. Gillis, R. N. Brogden, Drugs 1995, 49, 467.
- In vitro activity and fecal concentration of rifaximin after oral administration
- Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative
- In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species
- Rifaximin is a gut-specific human pregnane X receptor activator
- Rifaximin: A unique gastrointestinal-selective antibiotic for enteric diseases
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.